Artificial Intelligence For Response Assessment In Pediatric Neuro-Oncology (Ai-Rapno), Part 2: Challenges, Opportunities, And Recommendations For Clinical Translation

The Response Assessment in Pediatric Neuro-Oncology (RAPNO) criteria provide an important framework for evaluating treatment efficacy and tumour progression in clinical studies of paediatric brain tumours. As artificial intelligence (AI) rapidly transforms clinical practice, integrating AI into the RAPNO framework presents a unique opportunity to enhance quantitative, data-driven approaches for response assessment.